Opko Health Inc.
Here’s whether Opko Health Inc. (OPK) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: above the 50-day MA (medium-term momentum positive); 3-month momentum positive (+10.4%). Concerns: trading below the 200-day MA (long-term downtrend); 50-day MA is falling (-0.53% over 10 days); RSI 77 — overbought, elevated pullback risk. Currently 20.6% off its 52-week high. Score: -2/7.
OPK is trading below its 200-day MA ($1.30) — a key warning sign the longer-term trend is under pressure. With an RSI of 76.7, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +0.0% compares to +27.9% for SPY (trailed the market by 27.9%). The current 20.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.